U.S. Congress plans nearly $40 billion more for Ukraine, COVID aid to
wait
Send a link to a friend
[May 10, 2022] By
Patricia Zengerle
WASHINGTON (Reuters) -U.S. congressional
Democrats agreed to rush $39.8 billion in additional aid for Ukraine,
two sources familiar with the proposal said on Monday, easing fears a
delayed vote could interrupt the flow of U.S. weapons to the Kyiv
government.
The House of Representatives could pass the plan, which exceeds
President Joe Biden's request last month for $33 billion, as soon as
Tuesday, and Senate leaders said they were also prepared to move
quickly.
A proposal for additional COVID-19-related funding, which some Democrats
had wanted to combine with the emergency Ukraine funding, will now be
considered separately.
Biden on April 28 asked Congress for $33 billion to support Ukraine,
including more than $20 billion in military assistance. That proposal
was a dramatic escalation of U.S. funding for the war with Russia.
The new proposal includes an additional $3.4 billion for military aid
and $3.4 billion in humanitarian aid, the sources said.
Biden's fellow Democrats and Republicans both said they supported more
aid for Ukraine and would approve emergency funding quickly, but it was
delayed by disputes between the parties over whether additional funding
for COVID-19 relief or stiffer immigration controls should be included.
INTERRUPTING SUPPLIES?
The delay raised concerns across the capital.
Biden issued a statement calling on lawmakers to pass the funding and
get it to his desk for him to sign it into law in the next few days. "We
cannot allow our shipments of assistance to stop while we await further
congressional action," he said.
In letters to U.S. House Speaker Nancy Pelosi, top House Republican
Kevin McCarthy and key committee chairs in both the House and Senate,
Secretary of State Antony Blinken and Defense Secretary Lloyd Austin
said the military had enough funds to send weapons to Kyiv for just the
next two weeks.
"We need your help," Blinken and Austin wrote in the letters reviewed by
Reuters. They said there was only $100 million left to draw on under an
authority that allows the president to authorize the transfer of weapons
without congressional approval in response to an emergency.
[to top of second column]
|
A bird flies by the United States Capitol building in Washington,
U.S., March 17, 2022. REUTERS/Emily Elconin
"We expect to exhaust that authority no later than
May 19, 2022," they wrote.
Senate Republican Leader Mitch McConnell told
reporters he was pleased the Ukraine assistance was decoupled from
COVID-19 aid. He had advocated for a "clean" Ukraine bill repeatedly
in speeches in the Senate.
Some Democrats said they were disappointed the COVID-19 aid would be
considered separately.
"It would have been so much better for us to protect the United
States as well as worked to protect Ukraine," No. 2 Senate Democrat
Dick Durbin told reporters.
Asked if separating Ukraine aid hurts prospects for COVID-19 aid,
Durbin said, "It doesn't help. Putting those two together would have
been a positive."
In his statement, Biden called on Congress to move promptly on
COVID-19 funding. "Without timely COVID funding, more Americans will
die needlessly," he said.
"We will lose our place in line for America to order new COVID
treatments and vaccines for the fall, including next-generation
vaccines under development, and be unable to maintain our supply of
COVID tests."
Separately, Biden on Monday signed legislation that revives the
"Lend-Lease Act," a World War Two-era program that helped defeat
Hitler’s Germany by allowing Washington to lend or lease military
equipment to U.S. allies more quickly.
In this case, it will help those affected by Russia's invasion, such
as Poland and other eastern European countries as well as Ukraine.
(Reporting by Patricia Zengerle, additional reporting by Humeyra
Pamuk, Idrees Ali and Richard Cowan; Editing by Leslie Adler, Howard
Goller and Richard Pullin)
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |